Aelea Commodities Limited Reports Stellar H1 FY26 Results, Standalone Revenue Soars 110.64% YoY to Rs 17,362.08 Lakhs

Mumbai (Maharashtra) [India], October 21: Aelea Commodities Limited (BSE: ACLD), one of the leading integrated players in cashew processing, announced its unaudited financial results for the first half of FY26.

H1 FY26 Key Financial Highlights Standalone

Particulars (₹ In Lakhs) H1 FY26 H1 FY25 YoY Change
Revenue from Operations 17,362.08 8,242.70 110.64%
EBITDA 1,538.30 770.08 99.76%
Profit After Tax 883.71 376.60 134.65%
EPS (₹) 4.34 2.19 98.17%

H1 FY26 Key Financial Highlights Consolidated

Particulars (₹ In Lakhs) H1 FY26 H1 FY25 YoY Change
Revenue From Operations 17,369.28 8,774.03 97.96%
EBITDA 1,524.83 953.89 59.85%
Profit After Tax 870.21 558.05 55.94%
EPS (₹) 4.27 3.25 31.38%

Operational Highlights

During H1 FY26, the Company maintained robust capacity utilisation levels at its Surat plant and advanced preparatory work for Unit III, which will integrate renewable energy generation and by-product valorisation into its operations. The upcoming phase targets the conversion of Cashew Nut Shell Liquid (CNSL) into Cardanol, De- oil Cake, and Bio Charcoal, reflecting Aelea’s strategic move toward circular economy practices.

Strategic Developments

  • Unit II in Surat, commissioned in FY25, is now fully operational and supplying domestic markets only.
  • Land acquisition for Unit III completed, renewable energy integration plans under design.
  • Value-added product line under the ‘Tryble’ & ‘Supreme’ brand continues to gain traction in retail and e-commerce channels.

Global sourcing partnerships strengthened with suppliers across Côte d’Ivoire, Benin, Tanzania, and Indian MNC trading companies, etc, ensuring consistent raw material availability.

Commenting on the company’s performance in H1 FY26, Mr. Hozefa Shabbir Husain Jawadwala, Chairman and Managing Director of Aelea Commodities Limited, said, “The first half of FY26 marked a phase of strong execution, consolidation, and purposeful scale-building. We focused on optimizing capacity, deepening our sourcing network across Africa, and expanding product applications across food, fuel, feed, and fertility segments. These focused strategic actions have translated into robust operational and financial performance.

Compared to H1 FY25 standalone, revenue from operations for H1 FY26 stood at 17,362.08 lakhs, up 110.64% year-on-year, reflecting sustained growth momentum and improved capacity utilization. EBITDA rose sharply to 1,538.30 lakhs, up 99.76% YoY, with an EBITDA margin of 8.86% in H1 FY26, underscoring better operating leverage. PAT delivered a standout performance, more than doubling to 883.71 lakhs in H1 FY26, up 134.65% YoY, with a PAT margin of 5.09%, highlighting the success of our strategic initiatives and our ability to scale profitably. EPS stood at 4.34, marking a 98.17% YoY growth.

On a consolidated basis, revenue from operations in H1 FY26 stood at 17,369.28 lakhs, up 97.96% YoY. EBITDA increased 953.69 to 1,524.83 lakhs with a margin of 8.78%. PAT rose 558.05 to 870.21 lakhs with a margin of 5.01%, while EPS improved 3.25 to 4.27, highlighting sustained profitability.

With a strong first half setting the tone, the company expects to maintain this positive trajectory, further enhancing efficiency and margins in the coming months. Our vision remains clear: to transform Aelea into a diversified agri-value enterprise that combines profitability with purpose, built on a scalable, green, and globally competitive foundation.”

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

Altcoin Season Check: Chainlink Up 13.7%, Cardano Down 10%, and $BULLSKI on Stage Two

Key Takeaways Chainlink rose 13.7% and Monero 5.0% across seven days, the two clear winners among the majors. Cardano fell 10.0%, Uniswap 18.5% and Pepe 11.5% over the same week,…

Chandan Healthcare Delivers Strong Q1 FY27; Total Income at ₹82 Cr, EBITDA Surges 42% YoY to ₹21 Cr, PAT Rises 30% YoY

Lucknow, (Uttar Pradesh) [India], August 18: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading players in Diagnostic sector having Pan India presence, has announced…

You Missed

Acharya Bangalore B School Celebrates Convocation of MBA Batch 2024-26 with Pride and Excellence

  • By
  • August 26, 2026
Acharya Bangalore B School Celebrates Convocation of MBA Batch 2024-26 with Pride and Excellence

TradeFlock Reveals Most Influential Leaders in India 2026

  • By
  • August 26, 2026
TradeFlock Reveals Most Influential Leaders in India 2026

12 Exceptional Individuals Making a Difference In 2026

  • By
  • August 25, 2026
12 Exceptional Individuals Making a Difference In 2026

Harini Anand to Represent India at Miss Asia Global 2026

  • By
  • August 25, 2026
Harini Anand to Represent India at Miss Asia Global 2026

Anant Naad by Devi Chitralekhaji: When Music Became a Soulful Experience, Bhakti and Indian Music Resonated at Yashobhoomi

  • By
  • August 25, 2026
Anant Naad by Devi Chitralekhaji: When Music Became a Soulful Experience, Bhakti and Indian Music Resonated at Yashobhoomi

When a Child Is Not Learning Age-Appropriately: Why the Right Psychological Assessment Matters

  • By
  • August 25, 2026
When a Child Is Not Learning Age-Appropriately: Why the Right Psychological Assessment Matters